This medical stock is in the buy zone of a base. The glaucoma treatment developer raised its revenue forecast in its latest ...

Glaucoma is often called the "silent thief of sight" because it usually develops without pain or noticeable symptoms until ...

Glaucoma is a disease of the optic nerve that can cause vision loss. It is the second leading cause of blindness in the U.S. and the leading cause of irreversible blindness worldwide. Glaucoma is the ...

The article explains that the glaucoma treatment Racine specialists provide has evolved significantly as doctors have better understood how vision damage develops over time. Glauc ...

Shared insight on how the use and sequencing of therapies for glaucoma will evolve in coming years. Neil Minkoff, MD: Where do we see glaucoma therapy going in the next 24 to 36 months, due to ...

From memorable patient encounters to emerging therapies, OT talks with practitioners about opportunities and challenges in ...

A new study in mice has identified new treatment targets for glaucoma, including preventing a severe pediatric form of glaucoma, as well as uncovering a possible new class of therapy for the most ...

Macular degeneration and glaucoma can both lead to vision loss. However, macular degeneration tends to affect central vision while glaucoma affects side vision. The causes and treatment are also ...

A glaucoma diagnosis can feel alarming, especially knowing that optic nerve damage cannot be reversed. Rachel Simpson, MD, a glaucoma specialist at the John A. Moran Eye Center at University of Utah, ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma-related ocular surface disease is a significant and often underdiagnosed ocular comorbidity that can ...

A person with glaucoma may be able to wear contact lenses. However, this can depend on the severity of their condition, and the type of treatment they receive. Glaucoma is a condition in which ...

Glaucoma involves a high risk of losing sight. Researchers at Karolinska Institutet and St. Erik Eye Hospital, among others, have now studied the effects of nicotinamide, the amide of vitamin B₃, on ...